Sarah Romano - 06 Jan 2025 Form 4 Insider Report for Entero Therapeutics, Inc. (ENTO)

Role: Chief Financial Officer
Signature: /s/ Sarah Romano
Issuer symbol: ENTO
Transactions as of: 06 Jan 2025
Net transactions value: -$465
Form type: 4
Filing time: 08 Jan 2025, 16:23:52 UTC
Previous filing: 10 Oct 2024
Next filing: 11 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENTO	Common Stock	Sale	$465	-727	-4%	$0.6400	17,287	06 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	Includes unvested RSUs.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Includes unvested RSUs.